The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
Increasing evidence suggests that B lymphocytes play a central role in inhibiting the immune response against certain tumors, but the underlying mechanisms by which B cells facilitate tumor growth are still poorly understood. In this study, we investigated how the presence or absence of B cells affe...
Saved in:
| Published in: | Cancer Immunology, Immunotherapy Vol. 60; no. 5; pp. 609 - 619 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Berlin/Heidelberg
Springer-Verlag
01.05.2011
Springer Nature B.V |
| Subjects: | |
| ISSN: | 0340-7004, 1432-0851, 1432-0851 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Increasing evidence suggests that B lymphocytes play a central role in inhibiting the immune response against certain tumors, but the underlying mechanisms by which B cells facilitate tumor growth are still poorly understood. In this study, we investigated how the presence or absence of B cells affects expansion and function of T-regulatory cells (‘T-regs’) in a murine breast tumor model (EMT-6). We compared tumor growth, and the number and function of T-reg cells in wild-type immune-competent mice (ICM) and B-cell-deficient mice (BCDM). Mice were either tumor-naive or implanted with EMT-6 mammary adenocarcinoma cells. Tumor growth was markedly inhibited in BCDM, compared to wild-type mice (ICM). Increased T-reg expansion as defined by CD4+/CD25+/FOXP3+ cells was evident following EMT-6 inoculation in ICM in comparison with non-tumor-bearing mice or compared to BCDM in which tumor had been implanted. The percentage and absolute number of T-regs in the spleen, tumor draining lymph nodes, and tumor bed were significantly reduced in BCDM compared to ICM. T-reg function, measured by suppression and proliferation assays, was also reduced in tumor inoculated BCDM compared to ICM. Our studies indicate that absence of B cells may play a role in augmenting the T-cell anti-tumor response, in part due to effects on T-regulatory cell expansion and function. |
|---|---|
| AbstractList | Increasing evidence suggests that B lymphocytes play a central role in inhibiting the immune response against certain tumors, but the underlying mechanisms by which B cells facilitate tumor growth are still poorly understood. In this study, we investigated how the presence or absence of B cells affects expansion and function of T-regulatory cells (‘T-regs’) in a murine breast tumor model (EMT-6). We compared tumor growth, and the number and function of T-reg cells in wild-type immune-competent mice (ICM) and B-cell-deficient mice (BCDM). Mice were either tumor-naive or implanted with EMT-6 mammary adenocarcinoma cells. Tumor growth was markedly inhibited in BCDM, compared to wild-type mice (ICM). Increased T-reg expansion as defined by CD4+/CD25+/FOXP3+ cells was evident following EMT-6 inoculation in ICM in comparison with non-tumor-bearing mice or compared to BCDM in which tumor had been implanted. The percentage and absolute number of T-regs in the spleen, tumor draining lymph nodes, and tumor bed were significantly reduced in BCDM compared to ICM. T-reg function, measured by suppression and proliferation assays, was also reduced in tumor inoculated BCDM compared to ICM. Our studies indicate that absence of B cells may play a role in augmenting the T-cell anti-tumor response, in part due to effects on T-regulatory cell expansion and function. Increasing evidence suggests that B lymphocytes play a central role in inhibiting the immune response against certain tumors, but the underlying mechanisms by which B cells facilitate tumor growth are still poorly understood. In this study, we investigated how the presence or absence of B cells affects expansion and function of T-regulatory cells ('T-regs') in a murine breast tumor model (EMT-6). We compared tumor growth, and the number and function of T-reg cells in wild-type immune-competent mice (ICM) and B-cell-deficient mice (BCDM). Mice were either tumor-naive or implanted with EMT-6 mammary adenocarcinoma cells. Tumor growth was markedly inhibited in BCDM, compared to wild-type mice (ICM). Increased T-reg expansion as defined by CD4+/CD25+/FOXP3+ cells was evident following EMT-6 inoculation in ICM in comparison with non-tumor-bearing mice or compared to BCDM in which tumor had been implanted. The percentage and absolute number of T-regs in the spleen, tumor draining lymph nodes, and tumor bed were significantly reduced in BCDM compared to ICM. T-reg function, measured by suppression and proliferation assays, was also reduced in tumor inoculated BCDM compared to ICM. Our studies indicate that absence of B cells may play a role in augmenting the T-cell anti-tumor response, in part due to effects on T-regulatory cell expansion and function.Increasing evidence suggests that B lymphocytes play a central role in inhibiting the immune response against certain tumors, but the underlying mechanisms by which B cells facilitate tumor growth are still poorly understood. In this study, we investigated how the presence or absence of B cells affects expansion and function of T-regulatory cells ('T-regs') in a murine breast tumor model (EMT-6). We compared tumor growth, and the number and function of T-reg cells in wild-type immune-competent mice (ICM) and B-cell-deficient mice (BCDM). Mice were either tumor-naive or implanted with EMT-6 mammary adenocarcinoma cells. Tumor growth was markedly inhibited in BCDM, compared to wild-type mice (ICM). Increased T-reg expansion as defined by CD4+/CD25+/FOXP3+ cells was evident following EMT-6 inoculation in ICM in comparison with non-tumor-bearing mice or compared to BCDM in which tumor had been implanted. The percentage and absolute number of T-regs in the spleen, tumor draining lymph nodes, and tumor bed were significantly reduced in BCDM compared to ICM. T-reg function, measured by suppression and proliferation assays, was also reduced in tumor inoculated BCDM compared to ICM. Our studies indicate that absence of B cells may play a role in augmenting the T-cell anti-tumor response, in part due to effects on T-regulatory cell expansion and function. |
| Author | Tadmor, Tamar Rosenblatt, Joseph D. Podack, Eckhard R. Zhang, Yu Cho, Hyun-Mi |
| Author_xml | – sequence: 1 givenname: Tamar surname: Tadmor fullname: Tadmor, Tamar organization: Haematology Unit, Bnai Zion Medical Center – sequence: 2 givenname: Yu surname: Zhang fullname: Zhang, Yu organization: Division of Hematology/Oncology, University of Miami Sylvester Comprehensive Cancer Center – sequence: 3 givenname: Hyun-Mi surname: Cho fullname: Cho, Hyun-Mi organization: Division of Hematology/Oncology, University of Miami Sylvester Comprehensive Cancer Center – sequence: 4 givenname: Eckhard R. surname: Podack fullname: Podack, Eckhard R. organization: Department of Microbiology and Immunology, University of Miami Miller School of Medicine – sequence: 5 givenname: Joseph D. surname: Rosenblatt fullname: Rosenblatt, Joseph D. email: jrosenblatt@med.miami.edu organization: Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Division of Hematology/Oncology, University of Miami Sylvester Comprehensive Cancer Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21253724$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1v1DAQhi1URLeFH8AFWVw4BcYfsZMTgqp8SJW4LGfL60x2UyX2YieVtn-Cv4zTdPmoBJzG9jzvq_HMnJETHzwS8pzBawag3yQArngBjBVQa17cPiIrJkV-qUp2QlYgJBQaQJ6Ss5Su84FDXT8hp5zxUmguV-T7eofUbhJ6hzS09D3tD8N-F9xhxEQjNpPLccyQn4YNRmp9Q9vJu7ELfhasi4jbqbdjiAfqsO_THYJ-Z_1Rav3YFeM0hJgd0z74hLTz1NJhip1HuqSG0GD_lDxubZ_w2X08J18_XK4vPhVXXz5-vnh3VbgS2Fjo1lWWO8ktaMGbxjotsG1VIzbK8qpydiOFK2WjlZKqVVaXdSkqKRWHfGPinLxdfPfTZsDGoR-j7c0-doONBxNsZ_7M-G5ntuHGMAbZX8wOr-4dYvg2YRrN0KW5AdZjmJKpgYtSVgr-S1ZKSAG6kpl8-YC8DlP0uREZ4gpqrusMvfi99J81H4eaAb0ALoaUIrbGdaOdB5Z_0vWGgZnXxyzrY_L6mHl9zG1WsgfKo_m_NHzRpMz6LcZfNf9d9AMUbdmd |
| CitedBy_id | crossref_primary_10_3389_fimmu_2022_867902 crossref_primary_10_1155_2019_2592419 crossref_primary_10_1007_s00432_023_05508_1 crossref_primary_10_1038_nm_3554 crossref_primary_10_1111_all_14763 crossref_primary_10_1371_journal_pone_0199034 crossref_primary_10_1038_s41467_022_30613_z crossref_primary_10_3748_wjg_v28_i11_1088 crossref_primary_10_1080_2162402X_2015_1075112 crossref_primary_10_1146_annurev_immunol_020711_074934 crossref_primary_10_1038_onc_2017_35 crossref_primary_10_1038_s41598_024_61632_z crossref_primary_10_15252_emmm_201606914 crossref_primary_10_3389_fimmu_2021_697307 crossref_primary_10_3389_fonc_2023_1088129 crossref_primary_10_1073_pnas_2010981117 crossref_primary_10_3390_cancers3033370 crossref_primary_10_1002_JLB_5RU0518_199R crossref_primary_10_1016_j_celrep_2024_114920 crossref_primary_10_1111_apm_12439 crossref_primary_10_1200_JCO_2013_50_9471 crossref_primary_10_3389_fimmu_2019_03093 crossref_primary_10_1039_c4pp00051j crossref_primary_10_1038_s41581_018_0074_7 crossref_primary_10_1093_intimm_dxv034 crossref_primary_10_3389_fmolb_2021_673051 crossref_primary_10_3389_fgene_2022_805961 crossref_primary_10_1371_journal_pone_0067142 crossref_primary_10_1186_ar3907 crossref_primary_10_1093_intimm_dxw007 crossref_primary_10_3389_fimmu_2021_792691 crossref_primary_10_3748_wjg_v20_i29_9653 crossref_primary_10_4161_onci_25443 crossref_primary_10_1016_j_clim_2017_04_014 crossref_primary_10_1155_2014_314081 crossref_primary_10_1080_2162402X_2017_1336593 crossref_primary_10_3109_08820139_2014_917096 crossref_primary_10_1016_j_humimm_2015_09_006 crossref_primary_10_1158_2159_8290_CD_15_0822 crossref_primary_10_3390_cells10020355 crossref_primary_10_1111_sji_12407 crossref_primary_10_1080_2162402X_2017_1294296 crossref_primary_10_1038_srep46348 crossref_primary_10_1002_eji_201445036 crossref_primary_10_1080_2162402X_2020_1784529 crossref_primary_10_1007_s11523_017_0481_x crossref_primary_10_3390_ijms21238929 crossref_primary_10_1007_s12105_019_01095_1 crossref_primary_10_1007_s13277_015_4687_1 crossref_primary_10_1007_s00262_012_1313_6 crossref_primary_10_1002_eji_202250033 crossref_primary_10_1016_j_canlet_2015_04_030 crossref_primary_10_1016_j_ajpath_2021_05_006 crossref_primary_10_1371_journal_pbio_3001513 crossref_primary_10_1089_dna_2017_3814 crossref_primary_10_1016_j_yexcr_2019_01_021 crossref_primary_10_1007_s00262_022_03226_0 crossref_primary_10_1016_j_molimm_2016_01_011 crossref_primary_10_3389_fimmu_2022_830606 crossref_primary_10_1016_j_ccr_2014_04_026 crossref_primary_10_1038_s41598_022_16671_9 crossref_primary_10_1186_s40425_016_0145_x crossref_primary_10_1371_journal_pone_0095475 crossref_primary_10_1186_s13046_021_01983_x crossref_primary_10_1016_j_molimm_2014_01_014 crossref_primary_10_3390_ijms23147864 crossref_primary_10_1097_PPO_0b013e3182346320 crossref_primary_10_1007_s11481_015_9611_3 crossref_primary_10_3109_08916934_2013_856006 crossref_primary_10_1186_s40169_019_0226_9 crossref_primary_10_1016_j_jaci_2023_05_011 crossref_primary_10_1189_jlb_3A0414_213RR crossref_primary_10_1002_ijc_31850 crossref_primary_10_1016_j_ccr_2021_214126 crossref_primary_10_3389_fcell_2022_991840 crossref_primary_10_1007_s11596_019_2092_5 crossref_primary_10_1007_s12026_013_8472_1 crossref_primary_10_3390_jcm6020013 crossref_primary_10_1007_s11739_015_1377_3 crossref_primary_10_3892_ol_2017_5810 crossref_primary_10_1016_j_immuni_2015_04_005 crossref_primary_10_1155_2019_4650695 crossref_primary_10_4049_jimmunol_1800206 crossref_primary_10_1111_imm_13940 crossref_primary_10_1097_MIB_0000000000000955 crossref_primary_10_3389_fphar_2022_825287 crossref_primary_10_1111_cei_13362 crossref_primary_10_2217_imt_2018_0185 |
| Cites_doi | 10.1182/blood.V99.2.555 10.1111/j.1749-6632.2009.04651.x 10.1038/ni735 10.1182/blood-2006-10-053793 10.1111/j.1749-6632.2009.04939.x 10.1111/j.1365-3024.1995.tb01000.x 10.1038/nm0598-627 10.2337/diabetes.54.5.1407 10.4049/jimmunol.176.6.3301 10.1182/blood-2006-02-002774 10.1158/0008-5472.CAN-05-4217 10.4049/jimmunol.176.2.705 10.4049/jimmunol.175.1.21 10.1189/jlb.0604341 10.1111/j.0105-2896.2006.00411.x 10.4049/jimmunol.121.1.359 10.1097/00002371-200407000-00003 10.1093/annonc/mdh280 10.4049/jimmunol.178.7.4136 10.1182/blood-2007-12-129262 10.4049/jimmunol.175.3.1483 10.1084/jem.193.11.1295 10.1016/j.immuni.2008.03.017 10.4049/jimmunol.178.4.2155 10.1146/annurev.med.59.060906.220345 10.1182/blood-2007-02-068999 10.4049/jimmunol.0900270 10.1097/CJI.0b013e31816d1d6a 10.4049/jimmunol.161.12.6977 10.1158/0008-5472.CAN-05-3766 10.4049/jimmunol.179.4.2046 10.1073/pnas.0408679102 10.1002/ijc.21177 |
| ContentType | Journal Article |
| Copyright | Springer-Verlag 2011 Copyright Springer Nature B.V. May 2011 |
| Copyright_xml | – notice: Springer-Verlag 2011 – notice: Copyright Springer Nature B.V. May 2011 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
| DOI | 10.1007/s00262-011-0972-z |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central (NC Live) Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest Central Student AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-0851 |
| EndPage | 619 |
| ExternalDocumentID | PMC11028831 2324412211 21253724 10_1007_s00262_011_0972_z |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | United States--US |
| GeographicLocations_xml | – name: United States--US |
| GrantInformation_xml | – fundername: NCI NIH HHS grantid: 5-P01-CA-109094-04 |
| GroupedDBID | --- -53 -56 -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6J9 6NX 78A 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AAHNG AAIAL AAJKR AAJSJ AAKKN AANXM AANZL AARHV AARTL AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABEEZ ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMOR ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACACY ACBXY ACGFS ACHSB ACHVE ACHXU ACIHN ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACREN ACUDM ACULB ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGXO AFJLC AFKRA AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BVXVI C24 C6C CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GROUPED_DOAJ GRRUI GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IH2 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LK8 LLZTM M1P M4Y M7P MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPM RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SBL SCLPG SDE SDH SDM SHX SISQX SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z82 Z84 Z87 Z8O Z8V Z8Y Z91 ZGI ZMTXR ZOVNA ~EX ~KM AASML AAYXX ABDBE ABFSG ACSTC ADHKG AEZWR AFFHD AFHIU AGQPQ AHPBZ AHWEU AIXLP AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7T5 7XB 8FK AZQEC DWQXO GNUQQ H94 K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c501t-7fc8a2c42a0732ddac73eff6d3b6a288cab43c54d76646f6a75953844620f6a13 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 104 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000289728500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0340-7004 1432-0851 |
| IngestDate | Tue Nov 04 02:05:38 EST 2025 Fri Sep 05 12:04:43 EDT 2025 Fri Sep 05 14:32:24 EDT 2025 Tue Oct 07 13:41:36 EDT 2025 Thu Apr 03 07:06:23 EDT 2025 Sat Nov 29 01:50:24 EST 2025 Tue Nov 18 21:33:14 EST 2025 Fri Feb 21 02:33:09 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | B lymphocyte T-regulatory cells (T-reg) Immune-competent mice (ICM) B-cell-deficient mice (BCDM) Anti-tumor immunity |
| Language | English |
| License | http://www.springer.com/tdm |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c501t-7fc8a2c42a0732ddac73eff6d3b6a288cab43c54d76646f6a75953844620f6a13 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/11028831 |
| PMID | 21253724 |
| PQID | 862609279 |
| PQPubID | 48449 |
| PageCount | 11 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11028831 proquest_miscellaneous_902354860 proquest_miscellaneous_863430784 proquest_journals_862609279 pubmed_primary_21253724 crossref_citationtrail_10_1007_s00262_011_0972_z crossref_primary_10_1007_s00262_011_0972_z springer_journals_10_1007_s00262_011_0972_z |
| PublicationCentury | 2000 |
| PublicationDate | 2011-05-01 |
| PublicationDateYYYYMMDD | 2011-05-01 |
| PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | Cancer Immunology, Immunotherapy |
| PublicationTitleAbbrev | Cancer Immunol Immunother |
| PublicationTitleAlternate | Cancer Immunol Immunother |
| PublicationYear | 2011 |
| Publisher | Springer-Verlag Springer Nature B.V |
| Publisher_xml | – name: Springer-Verlag – name: Springer Nature B.V |
| References | Perricone, Smith, Claussen (CR37) 2004; 27 Levings, Sangregorio, Roncarolo (CR11) 2001; 193 Stasi, Cooper, Del Poeta (CR34) 2008; 112 Nabors, Nolan, Croop, Li, Farrell (CR16) 1995; 17 Kim, Fridlender, Dunn (CR27) 2008; 31 Reichardt, Dornbach, Rong (CR7) 2007; 110 Yanaba, Bouaziz, Matsushita, Tsubata, Tedder (CR22) 2009; 182 Rech, Vonderheide (CR26) 2009; 1174 Yanaba, Bouaziz, Haas (CR21) 2008; 28 Molina (CR30) 2008; 59 Brodt, Gordon (CR4) 1978; 121 Wolf, Wolf, Steurer, Gastl, Gunsilius, Grubeck-Loebenstein (CR24) 2003; 9 Shah, Divekar, Hilchey (CR2) 2005; 117 Kohm, McMahon, Podojil (CR13) 2006; 176 Zhou, Levitsky (CR5) 2007; 178 Mizoguchi, Bhan (CR20) 2006; 176 Brusko, Wasserfall, Clare-Salzler, Schatz, Atkinson (CR32) 2005; 54 Aklilu, Stadler, Markiewicz (CR38) 2004; 15 Qin, Richter, Schüler, Ibe, Cao, Blankenstein (CR19) 1998; 4 Chen, Jensen (CR8) 2007; 179 Kretschmer, Apostolou, Jaeckel, Khazaie, Boehmer (CR25) 2006; 212 Bystry, Aluvihare, Welch, Kallikourdis, Betz (CR9) 2001; 2 Onizuka, Tawara, Shimizu, Sakaguchi, Fujita, Nakayama (CR15) 1999; 59 Chapoval, Fuller, Kremlev, Kamdar, Evans (CR36) 1998; 161 Mease (CR31) 2008; 35 Stasi, Del Poeta, Stipa (CR35) 2007; 110 Beyer, Schultze (CR6) 2006; 108 Suto, Nakajima, Ikeda (CR29) 2002; 99 Baratelli, Lin, Zhu (CR12) 2005; 175 Valzasina, Piconese, Guiducci, Colombo (CR18) 2006; 66 Knoechel, Lohr, Kahn, Abbas (CR10) 2005; 175 Inoue, Leitner, Golding, Scott (CR3) 2006; 66 Couper, Blount, De Souza, Suffia, Belkaid, Riley (CR14) 2007; 178 Barbera-Guillem, Nelson, Barr (CR39) 2000; 48 Chen, Oppenheim, Howard (CR17) 2005; 78 Lemoine, Morva, Youinou, Jamin (CR23) 2009; 1173 LeBien, Tedder (CR1) 2008; 112 Chen, Schmidtt, Ginnopoulos (CR33) 2007; 31 Zelenay, Lopes-Carvalho, Caramalho, Moraes-Fontes, Rebelo, Demengeot (CR28) 2005; 102 KN Couper (972_CR14) 2007; 178 G Zhou (972_CR5) 2007; 178 972_CR28 RS Bystry (972_CR9) 2001; 2 972_CR30 Z Qin (972_CR19) 1998; 4 972_CR15 972_CR37 972_CR38 AJ Rech (972_CR26) 2009; 1174 972_CR35 972_CR36 972_CR11 AP Kohm (972_CR13) 2006; 176 972_CR34 972_CR31 972_CR10 972_CR17 972_CR39 972_CR18 GS Nabors (972_CR16) 1995; 17 P Reichardt (972_CR7) 2007; 110 A Suto (972_CR29) 2002; 99 972_CR4 972_CR2 972_CR3 972_CR8 TM Brusko (972_CR32) 2005; 54 972_CR6 S Lemoine (972_CR23) 2009; 1173 J Chen (972_CR33) 2007; 31 972_CR27 972_CR24 972_CR25 972_CR22 972_CR1 F Baratelli (972_CR12) 2005; 175 972_CR20 972_CR21 |
| References_xml | – volume: 161 start-page: 6977 issue: 12 year: 1998 end-page: 6984 ident: CR36 article-title: Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells publication-title: J Immunol – volume: 112 start-page: 1570 issue: 5 year: 2008 end-page: 1580 ident: CR1 article-title: B lymphocytes: how they develop and function publication-title: Blood – volume: 175 start-page: 1483 year: 2005 end-page: 1490 ident: CR12 article-title: Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells publication-title: J Immunol – volume: 212 start-page: 163 year: 2006 end-page: 169 ident: CR25 article-title: Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer publication-title: Immunol Rev – volume: 59 start-page: 3128 issue: 13 year: 1999 end-page: 3133 ident: CR15 article-title: Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody publication-title: Cancer Res – volume: 99 start-page: 555 year: 2002 end-page: 560 ident: CR29 article-title: CD4+CD25+ T-cell development is regulated by at least 2 distinct mechanisms publication-title: Blood doi: 10.1182/blood.V99.2.555 – volume: 121 start-page: 359 issue: 1 year: 1978 end-page: 62 ident: CR4 article-title: Anti-tumor immunity in B lymphocyte-deprived mice. I. Immunity to a chemically induced tumor publication-title: J Immunol. – volume: 59 start-page: 237 year: 2008 end-page: 250 ident: CR30 article-title: A decade of rituximab: improving survival outcomes in non-Hodgkin’s lymphoma publication-title: Annu Rev Med – volume: 9 start-page: 606 year: 2003 end-page: 612 ident: CR24 article-title: Increase of Regulatory T Cells in the Peripheral Blood of Cancer Patients publication-title: Clin Cancer Res – volume: 1173 start-page: 260 year: 2009 end-page: 267 ident: CR23 article-title: Regulatory B cells in autoimmune diseases: how do they work? publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2009.04651.x – volume: 2 start-page: 1126 issue: 12 year: 2001 end-page: 1132 ident: CR9 article-title: B cells, professional APCs recruit regulatory T cells via CCL4 publication-title: Nat Immunol doi: 10.1038/ni735 – volume: 66 start-page: 4488 issue: 8 year: 2006 end-page: 4495 ident: CR18 article-title: Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent publication-title: Cancer Res – volume: 176 start-page: 705 year: 2006 end-page: 710 ident: CR20 article-title: A case for regulatory B cells publication-title: J Immunol – volume: 178 start-page: 2155 year: 2007 end-page: 2162 ident: CR5 article-title: Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance publication-title: J Immunol – volume: 176 start-page: 3301 year: 2006 end-page: 3305 ident: CR13 article-title: Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4 CD25 T regulatory cells publication-title: J Immunol – volume: 179 start-page: 2046 year: 2007 end-page: 2050 ident: CR8 article-title: Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3+ CD4 T cells publication-title: J Immunol – volume: 178 start-page: 4136 year: 2007 end-page: 4146 ident: CR14 article-title: Incomplete Depletion and Rapid Regeneration of Foxp3 Regulatory T Cells Following Anti-CD25 Treatment in Malaria-Infected Mice publication-title: J Immunol – volume: 117 start-page: 574 issue: 4 year: 2005 end-page: 586 ident: CR2 article-title: Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells publication-title: Int J Cancer – volume: 66 start-page: 7741 year: 2006 end-page: 7747 ident: CR3 article-title: Inhibitory effects of B cells on antitumor immunity publication-title: Cancer Res – volume: 110 start-page: 1519 year: 2007 end-page: 1529 ident: CR7 article-title: Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse publication-title: Blood doi: 10.1182/blood-2006-10-053793 – volume: 110 start-page: 2924 issue: 8 year: 2007 end-page: 2930 ident: CR35 article-title: Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura publication-title: Blood – volume: 175 start-page: 21 issue: 1 year: 2005 end-page: 26 ident: CR10 article-title: The link between lymphocyte deficiency and autoimmunity: roles of endogenous T and B lymphocytes in tolerance publication-title: J Immunol – volume: 182 start-page: 7459 issue: 12 year: 2009 end-page: 7472 ident: CR22 article-title: The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals publication-title: J Immunol – volume: 1174 start-page: 99 year: 2009 end-page: 106 ident: CR26 article-title: Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2009.04939.x – volume: 31 start-page: 446 issue: 5 year: 2008 end-page: 457 ident: CR27 article-title: B cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models publication-title: J Immunother – volume: 15 start-page: 1109 issue: 7 year: 2004 end-page: 1114 ident: CR38 article-title: Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma publication-title: Ann Oncol – volume: 193 start-page: 1295 year: 2001 end-page: 1302 ident: CR11 article-title: Human Cd25+ Cd4+ T Regulatory cells suppress naive and memory T Cell Proliferation and can be expanded in vitro without loss of function publication-title: J Exp Med – volume: 78 start-page: 114 issue: 1 year: 2005 end-page: 121 ident: CR17 article-title: BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice publication-title: J Leukoc Biol – volume: 108 start-page: 804 issue: 3 year: 2006 end-page: 811 ident: CR6 article-title: Regulatory T cells in cancer publication-title: Blood – volume: 28 start-page: 639 issue: 5 year: 2008 end-page: 650 ident: CR21 article-title: Regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses publication-title: JI – volume: 27 start-page: 273 issue: 4 year: 2004 end-page: 281 ident: CR37 article-title: Enhanced efficacy of melanoma vaccines in the absence of B lymphocytes publication-title: J Immunother – volume: 17 start-page: 569 issue: 11 year: 1995 end-page: 579 ident: CR16 article-title: The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c x C57BL/6) F1 mice infected with Leishmania major publication-title: Parasite Immunol doi: 10.1111/j.1365-3024.1995.tb01000.x – volume: 48 start-page: 541 issue: 10 year: 2000 end-page: 549 ident: CR39 article-title: B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion publication-title: Cancer Immunol Immunother – volume: 4 start-page: 627 issue: 5 year: 1998 end-page: 630 ident: CR19 article-title: B cells inhibit induction of T cell-dependent tumor immunity publication-title: Nat Med doi: 10.1038/nm0598-627 – volume: 102 start-page: 4091 issue: 11 year: 2005 end-page: 4096 ident: CR28 article-title: Foxp3+CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion publication-title: Proc Natl Acad Sci USA – volume: 112 start-page: 1147 issue: 4 year: 2008 end-page: 1150 ident: CR34 article-title: Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with publication-title: Rituximab Blood – volume: 35 start-page: 1245 issue: 7 year: 2008 end-page: 1255 ident: CR31 article-title: B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application publication-title: J Rheumatol – volume: 31 start-page: 1133 year: 2007 end-page: 1139 ident: CR33 article-title: Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner publication-title: Int J Oncol – volume: 54 start-page: 1407 issue: 5 year: 2005 end-page: 1414 ident: CR32 article-title: Functional defects, the influence of age on the frequency of CD4+CD25+ T-cells in type 1 diabetes publication-title: Diabetes doi: 10.2337/diabetes.54.5.1407 – volume: 176 start-page: 3301 year: 2006 ident: 972_CR13 publication-title: J Immunol doi: 10.4049/jimmunol.176.6.3301 – volume: 1173 start-page: 260 year: 2009 ident: 972_CR23 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2009.04651.x – ident: 972_CR24 – ident: 972_CR6 doi: 10.1182/blood-2006-02-002774 – ident: 972_CR18 doi: 10.1158/0008-5472.CAN-05-4217 – volume: 31 start-page: 1133 year: 2007 ident: 972_CR33 publication-title: Int J Oncol – volume: 110 start-page: 1519 year: 2007 ident: 972_CR7 publication-title: Blood doi: 10.1182/blood-2006-10-053793 – ident: 972_CR20 doi: 10.4049/jimmunol.176.2.705 – ident: 972_CR10 doi: 10.4049/jimmunol.175.1.21 – volume: 99 start-page: 555 year: 2002 ident: 972_CR29 publication-title: Blood doi: 10.1182/blood.V99.2.555 – ident: 972_CR39 – volume: 17 start-page: 569 issue: 11 year: 1995 ident: 972_CR16 publication-title: Parasite Immunol doi: 10.1111/j.1365-3024.1995.tb01000.x – ident: 972_CR17 doi: 10.1189/jlb.0604341 – ident: 972_CR1 – volume: 4 start-page: 627 issue: 5 year: 1998 ident: 972_CR19 publication-title: Nat Med doi: 10.1038/nm0598-627 – ident: 972_CR25 doi: 10.1111/j.0105-2896.2006.00411.x – volume: 54 start-page: 1407 issue: 5 year: 2005 ident: 972_CR32 publication-title: Diabetes doi: 10.2337/diabetes.54.5.1407 – ident: 972_CR4 doi: 10.4049/jimmunol.121.1.359 – volume: 1174 start-page: 99 year: 2009 ident: 972_CR26 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.2009.04939.x – ident: 972_CR37 doi: 10.1097/00002371-200407000-00003 – ident: 972_CR38 doi: 10.1093/annonc/mdh280 – volume: 178 start-page: 4136 year: 2007 ident: 972_CR14 publication-title: J Immunol doi: 10.4049/jimmunol.178.7.4136 – ident: 972_CR34 doi: 10.1182/blood-2007-12-129262 – volume: 175 start-page: 1483 year: 2005 ident: 972_CR12 publication-title: J Immunol doi: 10.4049/jimmunol.175.3.1483 – ident: 972_CR11 doi: 10.1084/jem.193.11.1295 – ident: 972_CR21 doi: 10.1016/j.immuni.2008.03.017 – volume: 178 start-page: 2155 year: 2007 ident: 972_CR5 publication-title: J Immunol doi: 10.4049/jimmunol.178.4.2155 – ident: 972_CR30 doi: 10.1146/annurev.med.59.060906.220345 – ident: 972_CR35 doi: 10.1182/blood-2007-02-068999 – ident: 972_CR22 doi: 10.4049/jimmunol.0900270 – ident: 972_CR27 doi: 10.1097/CJI.0b013e31816d1d6a – ident: 972_CR31 – ident: 972_CR15 – volume: 2 start-page: 1126 issue: 12 year: 2001 ident: 972_CR9 publication-title: Nat Immunol doi: 10.1038/ni735 – ident: 972_CR36 doi: 10.4049/jimmunol.161.12.6977 – ident: 972_CR3 doi: 10.1158/0008-5472.CAN-05-3766 – ident: 972_CR8 doi: 10.4049/jimmunol.179.4.2046 – ident: 972_CR28 doi: 10.1073/pnas.0408679102 – ident: 972_CR2 doi: 10.1002/ijc.21177 |
| SSID | ssj0042099 ssj0001254 |
| Score | 2.3455877 |
| Snippet | Increasing evidence suggests that B lymphocytes play a central role in inhibiting the immune response against certain tumors, but the underlying mechanisms by... |
| SourceID | pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 609 |
| SubjectTerms | Animals Antibodies Antibodies, Monoclonal - immunology B-Lymphocytes - immunology Cancer Cancer Research CD4 Antigens - analysis Cell Line, Tumor Cell Proliferation Cells Female Flow Cytometry Forkhead Transcription Factors - analysis Immunology Immunophenotyping Interleukin-2 Receptor alpha Subunit - analysis Lymphatic system Lymphocyte Count Lymphocyte Depletion Lymphocytes Mammary Neoplasms, Experimental - immunology Mammary Neoplasms, Experimental - pathology Medicine Medicine & Public Health Mice Mice, Inbred BALB C Mice, Knockout Neoplasm Transplantation Oncology Original Original Article Spleen T-Lymphocytes - immunology T-Lymphocytes, Regulatory - immunology |
| SummonAdditionalLinks | – databaseName: Public Health Database dbid: 8C1 link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9UwDI9gILQL32zdAOXACRTRJmmSntCYmDjAxGFIu1VpkmpP2trRvjfp7Z_gX8ZOP9Bj2i6cqihO1fRnO07s2IS8wxxtAfb_LPVOMRmEZLbKU5B4Z2SVqcKpeFH4mz4-NqenxY8xNqcfwyonnRgVtW8dnpF_jJZ3wXXx6fIXw6JR6FwdK2jcJw8ynkqUS3M4R3hIvBUanQgYNAftyamZxhyiXGFMAuylC83Z9eaydMPWvBky-Y_fNC5HR0_-cyJPyePRDqUHA-M8I_dC85w8-j562l-Q38A_1FY9Cj5ta_qZnq8B-NatwTalHSZ8hSdYj3SoKUJt4ykukgg0Djhh3VDmvu3WFN0DfSQJzRny2TAUUF2w5eqi7eCNMVY30EVDLb1AH0CgQ1cs1vOS_Dz6cnL4lY3FG5jL02zJdO2M5U5yC0qEe2-dFqGulReVstwYZyspXC69VkqqWlmdF6B8YXfKU2hl4hXZatom7BIKm3-RWhnANvMyN97wCi9hOa50bWvuE5JO2JVuzGyOBTbOyzknc4S7BLhLhLu8Tsj7ecjlkNbjLuL9CclylPC-nGFMCJ17QTTxh9omtCskERJUqJG3kxSYbgjrgCVkZ2Cw-XPApsiF5jDYbLDeTICJwTd7msVZTBCeodVoRJaQDxOX_v3wW6e5d-c098n2cJyOsZ6vydayW4U35KG7Wi767m0UvD8cbzYD priority: 102 providerName: ProQuest |
| Title | The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model |
| URI | https://link.springer.com/article/10.1007/s00262-011-0972-z https://www.ncbi.nlm.nih.gov/pubmed/21253724 https://www.proquest.com/docview/862609279 https://www.proquest.com/docview/863430784 https://www.proquest.com/docview/902354860 https://pubmed.ncbi.nlm.nih.gov/PMC11028831 |
| Volume | 60 |
| WOSCitedRecordID | wos000289728500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Health & Medical Collection (Proquest) customDbUrl: eissn: 1432-0851 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0042099 issn: 0340-7004 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Biological Science Database (NC LIVE) customDbUrl: eissn: 1432-0851 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0042099 issn: 0340-7004 databaseCode: M7P dateStart: 19970101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1432-0851 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0042099 issn: 0340-7004 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1432-0851 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0042099 issn: 0340-7004 databaseCode: 8C1 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1432-0851 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0042099 issn: 0340-7004 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtQwcERbhHrhXVgKKx84gSIljmM7R1q14gCrVSlob5HjOOpKbYKS3Urbn-CXmXEeaClFgksiy-MoseeZeQG8pRptDu3_ICysDISLRWDyJESKt1rkkUyt9InCn9RspheLdN7ncbdDtPvgkvScekx2I3OBwgjQ_E0VD252YA-lnSZqPPvybWS_KLHFMBCUGOr9CBQ3h-PBr_mn521Lplvq5u2oyd9cp14inT76r295DA97BZR96DDmCdxz1VN48Ll3sT-DH4g4zOQtUTyrS3bELjd44rXdoFLKGqr0indUG1nXTISZqmAkHemEacF50HT97etmw8gv0HoQV10QgnVL8TiXwWp9VTf4RB-k69iyYoZd0c9_x7op36XnOXw9PTk__hj0XRsCm4TRKlCl1YZbwQ1yD14UxqrYlaUs4lwarrU1uYhtIgolpZClNCpJkeuiWcpDHEXxAexWdeVeAkOrPw6NcKiUFSLRheY5ZV9ZLlVpSl5MIBxOLLN9SXPqrHGZjcWY_UZnuNEZbXR2M4F345LvXT2PvwEfDmiQ9aTdZt4ETLlKJ8DGWaRJ2lBTuXpNILFA3qnF3SAp1RmiBmATeNGh1fg6qEwkseK4WG8h3AhAFcG3Z6rlha8MHpG6qONoAu8HvPv14nd-5qt_gj6E_e6_OgV9vobdVbN2b-C-vV4t22YKO2qh_FXjVR9HU9g7OpnNz6YUVTufelr9CXqrNNc |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoAL70coDx_gAopIHMdODgjxqlp1u-KwSHsLjuPQldqkJLug7Z_gl_AfmXE2QUvV3nrgtIo8jhLvN-OZzPgbgOfE0WYx_veDwkhf2Ej4Oo8D1HiTiDyUqZHuoPBIjcfJdJp-3oDf_VkYKqvsbaIz1EVt6Bv5a-d5p1ylb4-_-9Q0ipKrfQeNDhV7dvkTI7b2ze5H_HtfcL79afJhx181FfBNHIRzX5Um0dwIrhHcvCi0UZEtS1lEudQ8SYzORWRiUSgphSylVnGKRgGjJh7gVRjhfS_BZTTjiirI1HSI7wSdQnVJCyrSw-s-iRo4zlIuqQYCY_dUcf9kfRs85dueLtH8J0_rtr_tm__Zwt2CGys_m73rFOM2bNjqDlzdX1US3IVfqB9M5y0ZNlaX7D07XCKwa7NE35s1RGiLv-gds65nCtNVwcgJICDThInf2G_U-6xulozSH60TsdUB6VE3FVE78-eLo7rBO7paZMtmFdPsiHIclnVDrhnRPfhyIctxHzarurIPgdkc40AtLPqehYiTIuE5HTIzXKpSl7zwIOixkpkVczs1EDnMBs5pB68M4ZURvLITD14OU4472pLzhLd65GQrC9ZmA2w8YMMomh5aUF3ZekEikcAtIhFni6REp0R9zjx40AF6eBz0meJIcZycrEF9ECDi8_WRanbgCNBD8oqTKPTgVa8Vfx_8zNd8dO5rPoNrO5P9UTbaHe9twfUudUB1rY9hc94s7BO4Yn7MZ23z1Ck9g68XrSx_AHlwkuM |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VFlVceBdCefgAF1DUxHGc5IAQpV1RtaxWqEi9Bcdx6EptUpJd0PZP8Hv4d8w4D7RU7a0HTqvI4yjxfjP-JjOeAXhJNdoM-v-ul2vpChMIV2WhhxqvY5H5MtHSHhQ-iMbj-OgomazA7_4sDKVV9jbRGuq80vSNfMsy74RHyVbRZUVMdkbvzr671ECKAq19N40WIftm8RO9t-bt3g7-1a84H-0efvjodg0GXB16_syNCh0rrgVXCHSe50pHgSkKmQeZVDyOtcpEoEORR1IKWUgVhQkaCPSguIdXfoD3vQFrEXIMVK617d3x5HO_DQg6k2pDGJSyh9d9SNWzFUy5pIwI9OSTiLvny5viBaZ7MWHzn6it3QxHd_7jZbwLtzsGzt63KnMPVkx5H9Y_dTkGD-AXag5TWUMmj1UF22YnC4R8pRfIyllNpW7xF3kza7upMFXmjOgBQZwmHLq1-UZd0ap6wSgw0lgRUx6ThrVTEc9TdzY_rWq8o81SNmxaMsVOKfphWDtk2xQ9hC_XshwbsFpWpXkMzGToISphkJXmIozzmGd0_ExzGRWq4LkDXo-bVHc13am1yEk6VKO2UEsRailBLT134PUw5awtaHKV8GaPorSzbU06QMgBNoyiUaIFVaWp5iQSCNw8YnG5SEKFlqgDmgOPWnAPj4NsKgwijpPjJdgPAlQSfXmknB7b0ug-8eU48B1402vI3we_9DWfXPmaL2AddSQ92Bvvb8KtNqZACa9PYXVWz80zuKl_zKZN_byzAAy-Xre2_AHcsp0E |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+absence+of+B+lymphocytes+reduces+the+number+and+function+of+T-regulatory+cells+and+enhances+the+anti-tumor+response+in+a+murine+tumor+model&rft.jtitle=Cancer+Immunology%2C+Immunotherapy+%3A+CII&rft.au=Tadmor%2C+Tamar&rft.au=Zhang%2C+Yu&rft.au=Cho%2C+Hyun-Mi&rft.au=Podack%2C+Eckhard+R.&rft.date=2011-05-01&rft.pub=Springer-Verlag&rft.issn=0340-7004&rft.eissn=1432-0851&rft.volume=60&rft.issue=5&rft.spage=609&rft.epage=619&rft_id=info:doi/10.1007%2Fs00262-011-0972-z&rft_id=info%3Apmid%2F21253724&rft.externalDocID=PMC11028831 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-7004&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-7004&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-7004&client=summon |